Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$70.1 - $85.17 $15.8 Million - $19.2 Million
-226,013 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$77.0 - $99.34 $2.18 Million - $2.81 Million
28,300 Added 14.31%
226,013 $19.2 Million
Q4 2018

Feb 14, 2019

SELL
$83.85 - $110.34 $13.7 Million - $18.1 Million
-163,963 Reduced 45.33%
197,713 $17 Million
Q3 2018

Nov 14, 2018

BUY
$97.14 - $113.31 $670,266 - $781,839
6,900 Added 1.94%
361,676 $41 Million
Q2 2018

Aug 14, 2018

BUY
$74.5 - $108.91 $8.67 Million - $12.7 Million
116,330 Added 48.79%
354,776 $36.8 Million
Q1 2018

May 15, 2018

BUY
$58.36 - $83.18 $2.45 Million - $3.5 Million
42,050 Added 21.41%
238,446 $0
Q4 2017

Feb 14, 2018

BUY
$77.49 - $98.41 $15.2 Million - $19.3 Million
196,396
196,396 $15.8 Million

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.